×
  • Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Retinal Surgery Device Market

    ID: MRFR/HC/41847-HCR
    111 Pages
    Rahul Gotadki
    October 2025

    Retinal Surgery Device Market Research Report By Device Type (Vitrectomy Devices, Retinal Lasers, Pneumatic Retinopexy Devices, Scleral Buckling Devices), By Procedure Type (Vitrectomy, Laser Photocoagulation, Retinal Detachment Surgery, Macular Hole Surgery), By End User (Hospitals, Ambulatory Surgical Centers, Ophthalmology Clinics), By Technology (Digital Imaging Technology, Robotic-Assisted Technology, Laser Technology) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Retinal Surgery Device Market Infographic
    Purchase Options

    Retinal Surgery Device Market Summary

    The Global Retinal Surgery Device Market is projected to grow from 4.7 USD Billion in 2024 to 7.5 USD Billion by 2035.

    Key Market Trends & Highlights

    Retinal Surgery Device Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 4.34 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 7.5 USD Billion, reflecting a robust growth trajectory.
    • In 2024, the market is valued at 4.7 USD Billion, indicating a strong foundation for future expansion.
    • Growing adoption of advanced surgical techniques due to increasing prevalence of retinal disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 4.7 (USD Billion)
    2035 Market Size 7.5 (USD Billion)
    CAGR (2025-2035) 4.34%

    Major Players

    Lumenis, Visionix, Abbott Laboratories, Nidek, Optos, Hoya, Topcon, Carl Zeiss, Heidelberg Engineering, Bausch Health, Novartis, Alcon, Regeneron Pharmaceuticals, Medtronic, CenterVue

    Retinal Surgery Device Market Trends

    The continuous growth in the Global Retinal Surgery Device Market is propelled by factors such as the growing incidence of retinal disorders, the aging population, and innovations in surgical techniques. The rise in the volume of eye disorders like diabetic retinopathy and age-related macular degeneration has created a demand for surgical solutions. In addition, technological advancements have shifted the focus toward the development of advanced minimally invasive techniques that improve outcomes and expedite recovery times, which is supportive of market growth. 

    Furthermore, the rising concern about eye health and the focus on preventative medicine is encouraging patients to seek medical attention at an earlier stage, which is also supportive of market growth.Exploration of opportunities in the Global Retinal Surgery Device Market is on the rise.

    Companies are focusing on developing innovative products that incorporate artificial intelligence and digital technologies to improve surgical precision and outcomes. This trend towards incorporating smart technology is creating new avenues for market players to enhance their product offerings. Furthermore, collaborations between medical device manufacturers and healthcare providers are essential to ensure the successful integration of these advanced devices in clinical settings. 

    Expanding into emerging markets presents another opportunity, as increasing access to healthcare infrastructure and services drives demand for retinal surgery devices.In recent times, there has been a noticeable trend towards personalized treatment options that cater to individual patient needs. Healthcare professionals are recognizing the importance of tailoring surgical approaches to optimize patient outcomes.

    Additionally, the emphasis on training and education for surgeons is becoming more prominent, ensuring they are well-equipped to utilize the latest devices effectively. 

    The rise of telemedicine and online consultations is also shaping the market landscape as patients seek convenient ways to access specialist care for retinal issues. As the market continues to evolve, these trends indicate a proactive approach toward improving retinal health and surgical outcomes.

    Retinal Surgery Device Market Drivers

    Market Growth Projections

    The Global Retinal Surgery Device Market Industry is poised for substantial growth, with projections indicating a market value of 4.7 USD Billion in 2024 and an anticipated increase to 7.5 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate of 4.34% from 2025 to 2035, driven by various factors including technological advancements, increasing prevalence of eye disorders, and rising healthcare expenditures. The market dynamics suggest a robust future for retinal surgery devices, as stakeholders adapt to evolving healthcare needs and patient demands.

    Rising Healthcare Expenditure

    The Global Retinal Surgery Device Market Industry is benefiting from increasing healthcare expenditure across various regions. Governments and private sectors are investing more in healthcare infrastructure, which includes the procurement of advanced surgical devices. This trend is particularly evident in developing nations, where improving healthcare access is a priority. Enhanced funding allows for the acquisition of cutting-edge retinal surgery devices, thus facilitating better treatment options for patients. As healthcare spending continues to rise, the market is likely to see sustained growth, aligning with the projected increase in market value.

    Increasing Prevalence of Eye Disorders

    The Global Retinal Surgery Device Market Industry is experiencing growth due to the rising incidence of eye disorders such as diabetic retinopathy and age-related macular degeneration. As populations age and lifestyle factors contribute to these conditions, the demand for surgical interventions increases. For instance, the World Health Organization indicates that the prevalence of diabetic retinopathy is expected to rise significantly, necessitating advanced surgical devices. This trend is reflected in the market's projected value of 4.7 USD Billion in 2024, with expectations to reach 7.5 USD Billion by 2035, indicating a robust growth trajectory.

    Aging Population and Demographic Shifts

    The demographic shift towards an aging population is a significant factor influencing the Global Retinal Surgery Device Market Industry. As individuals age, they become more susceptible to various eye disorders, thereby increasing the demand for surgical interventions. The United Nations projects that the global population aged 60 years and older will double by 2050, further amplifying the need for effective retinal surgeries. This demographic trend is expected to drive market growth, as healthcare systems adapt to accommodate the rising number of patients requiring retinal surgery.

    Growing Awareness and Screening Programs

    Awareness campaigns and screening programs for eye health are crucial drivers of the Global Retinal Surgery Device Market Industry. Initiatives aimed at educating the public about the importance of early detection of retinal diseases are leading to increased patient referrals for surgical interventions. Organizations are implementing community outreach programs that promote regular eye examinations, thereby identifying conditions that require surgical treatment. This proactive approach not only enhances patient outcomes but also stimulates demand for retinal surgery devices, contributing to the overall market growth.

    Technological Advancements in Surgical Devices

    Innovations in retinal surgery devices are propelling the Global Retinal Surgery Device Market Industry forward. Enhanced imaging technologies, such as optical coherence tomography, and minimally invasive surgical techniques are improving patient outcomes and operational efficiency. These advancements not only facilitate more precise surgeries but also reduce recovery times. As a result, healthcare providers are increasingly adopting these state-of-the-art devices, contributing to market growth. The anticipated compound annual growth rate of 4.34% from 2025 to 2035 underscores the potential for continued innovation and market expansion.

    Market Segment Insights

    Retinal Surgery Device Market Device Type Insights

    The Global Retinal Surgery Device Market revenue reached 4.7 USD Billion in 2024, reflecting a positive growth trajectory within the Device Type segment. This segment encompasses various essential devices that play a critical role in retinal surgeries. Among these, Vitrectomy Devices hold a majority holding value of 1.9 USD Billion in 2024, demonstrating their dominant role in the market.  This high valuation illustrates the increasing number of vitrectomy procedures due to the rising prevalence of retinal disorders, which continuously drives demand.

    Following Vitrectomy Devices, Retinal Lasers also contribute significantly, with a market valuation of 1.2 USD Billion in 2024. These devices are crucial for various retinal treatments, including diabetic retinopathy and retinal tears, making them indispensable for eye care professionals. Pneumatic Retinopexy Devices, valued at 0.8 USD Billion in 2024, are essential for certain types of retinal detachments, showcasing their specialized application within the market.

    While they capture a smaller percentage of the market, their importance should not be understated, as they serve a niche but critical function in retinal surgeries. Lastly, Scleral Buckling Devices, with a valuation of 1.0 USD Billion in 2024, also play a vital role in the management of retinal detachments

    . The consistent demand for these devices emphasizes their significance in surgical practice and their contribution to patient outcomes. As the market progresses toward 2035, valuations for these devices are expected to increase considerably, further solidifying their positions. Vitrectomy Devices are projected to reach 3.0 USD Billion, while Retinal Lasers could see a rise to 2.0 USD Billion, indicating that they will maintain their significant roles in the future landscape of the Global Retinal Surgery Device Market.

    Pneumatic Retinopexy Devices and Scleral Buckling Devices are also expected to grow, reaching 1.3 USD Billion and 1.2 USD Billion, respectively. These market statistics underscore the continuous advancements in technology, which are anticipated to improve surgical outcomes and drive market growth.

    Retinal Surgery Device Market Procedure Type Insights

    The Global Retinal Surgery Device Market is categorized by various Procedure Types, with a market value of 4.7 USD Billion by 2024. This segment includes critical procedures such as Vitrectomy, Laser Photocoagulation, Retinal Detachment Surgery, and Macular Hole Surgery, each playing a vital role in the treatment of retinal disorders.

    Vitrectomy has become a preferred method due to its effectiveness in addressing complications like diabetic retinopathy and retinal detachments, holding a significant share of the market. Laser Photocoagulation remains a key technique for managing conditions such as diabetic retinopathy and retinal vein occlusions, as it provides targeted treatment to preserve vision.Retinal Detachment Surgery is crucial for preventing permanent vision loss, making it a substantial focus area within the market. 

    Additionally, Macular Hole Surgery addresses serious cases with promising outcomes, thereby enhancing patient quality of life. The growth of the Global Retinal Surgery Device Market is influenced by advancements in technology, increased awareness of retinal diseases, and a growing elderly population susceptible to age-related eye conditions.

    However, challenges such as high treatment costs and a shortage of skilled professionals could impact market expansion.The Global Retinal Surgery Device Market data reveals a steady increase in demand, driven by the need for effective treatment solutions.

    Retinal Surgery Device Market End User Insights

    The Global Retinal Surgery Device Market shows a robust structure in terms of its end-user segmentation, primarily including hospitals, ambulatory surgical centers, and ophthalmology clinics. As of 2024, the market is projected to be valued at 4.7 billion USD, reflecting the growing need for advanced medical technologies.

    Hospitals typically play a critical role, often serving as the primary healthcare providers for retinal surgeries due to their comprehensive facilities and availability of specialized professionals. Ambulatory surgical centers are gaining traction, providing cost-effective and efficient options for patients seeking less invasive procedures.

    Meanwhile, ophthalmology clinics are significant due to their focused expertise in eye care, which aids in the rising prevalence of retinal conditions. The increasing incidence of age-related macular degeneration and diabetic retinopathy, coupled with advancements in surgical techniques, continues to drive the growth of the Global Retinal Surgery Device Market.

    Challenges such as high costs associated with cutting-edge devices may hinder growth, yet opportunities exist in expanding access to care and investment in innovative technologies. 

    Comprehensive Global Retinal Surgery Device Market data reveals that this market is poised for steady growth in the coming years, with ongoing trends supporting enhanced patient outcomes and operational efficiencies across all segments.

    Retinal Surgery Device Market Technology Insights

    The Global Retinal Surgery Device Market has shown significant growth in the Technology segment, which is projected to reach a value of 4.7 billion USD by 2024. This segment is intricately divided into various technologies, each contributing uniquely to market dynamics. Digital Imaging Technology plays a critical role in enhancing the precision and efficiency of retinal surgery, leading to better patient outcomes, thereby gaining considerable traction in the market.

    Robotic-assisted technology stands out due to its ability to provide surgeons with enhanced dexterity and visualization, which is increasingly being adopted for complex procedures. On the other hand, Laser Technology dominates the landscape by offering minimally invasive options that reduce recovery time and improve surgical accuracy.

    These technological advancements cater to rising demands for effective and safe retinal surgeries, which fuels overall market growth. The Global Retinal Surgery Device Market statistics reflect a vibrant industry where innovation and improved surgical outcomes are at the forefront, and ongoing developments in these technologies are set to create further opportunities in the coming years.

    Get more detailed insights about Retinal Surgery Device Market

    Key Companies in the Retinal Surgery Device Market market include

    Industry Developments

    • Q2 2024: Alcon Launches New NGENUITY 3D Visualization System for Retinal Surgery Alcon announced the commercial launch of its next-generation NGENUITY 3D Visualization System, designed to enhance visualization and workflow in retinal surgery procedures.
    • Q1 2024: BVI Acquires Medical Device Innovator Benz Research & Development BVI, a global ophthalmic device company, completed the acquisition of Benz Research & Development, expanding its portfolio in the retinal surgery device sector.
    • Q2 2024: IRIDEX Receives FDA 510(k) Clearance for New Cyclo G6 Glaucoma Laser Platform IRIDEX Corporation announced it received FDA 510(k) clearance for its new Cyclo G6 platform, which includes features for retinal and glaucoma procedures.
    • Q1 2024: DORC Announces Partnership with ZEISS to Integrate Surgical Visualization for Retinal Procedures Dutch Ophthalmic Research Center (DORC) and ZEISS announced a strategic partnership to integrate DORC’s EVA surgical system with ZEISS visualization technology for advanced retinal surgery.
    • Q2 2024: Ocutrx Technologies Raises $14 Million in Series B Funding to Advance Retinal Surgery Platform Ocutrx Technologies secured $14 million in Series B funding to accelerate development and commercialization of its OcuLenz AR surgical visualization system for retinal procedures.
    • Q1 2024: Topcon Medical Systems Opens New Manufacturing Facility for Retinal Imaging and Surgery Devices Topcon Medical Systems inaugurated a new manufacturing facility in the U.S. dedicated to the production of advanced retinal imaging and surgery devices.
    • Q2 2024: Carl Zeiss Meditec Receives CE Mark for QUATERA 700 Surgical Platform with Retinal Module Carl Zeiss Meditec announced it received CE Mark approval for its QUATERA 700 surgical platform, which now includes a dedicated module for retinal surgery.
    • Q1 2024: Johnson & Johnson Vision Appoints New Head of Surgical Vision Business Johnson & Johnson Vision announced the appointment of a new global head for its Surgical Vision business, overseeing the company’s retinal surgery device portfolio.
    • Q2 2024: Nidek Launches New Constellation Vitrectomy System for Retinal Surgery Nidek announced the launch of its Constellation Vitrectomy System, designed to improve efficiency and outcomes in retinal surgery.
    • Q1 2024: Bausch + Lomb Receives FDA Approval for New Retinal Laser Device Bausch + Lomb received FDA approval for its latest retinal laser device, expanding its portfolio of surgical solutions for retinal disorders.
    • Q2 2024: Synergetics USA Announces Strategic Distribution Agreement for Retinal Surgery Instruments in Europe Synergetics USA entered into a strategic distribution agreement to expand the availability of its retinal surgery instruments across European markets.
    • Q1 2024: Retina Implant AG Secures $10 Million in Funding to Advance Subretinal Implant Technology Retina Implant AG raised $10 million in new funding to support clinical development and commercialization of its subretinal implant for vision restoration.

    Future Outlook

    Retinal Surgery Device Market Future Outlook

    The Retinal Surgery Device Market is projected to grow at a 4.34% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of retinal disorders, and rising healthcare expenditures.

    New opportunities lie in:

    • Develop innovative minimally invasive surgical devices to enhance patient recovery times.
    • Invest in AI-driven diagnostic tools for early detection of retinal diseases.
    • Expand telemedicine solutions for remote monitoring and consultation in retinal care.

    By 2035, the market is expected to demonstrate robust growth, reflecting advancements in technology and increased demand.

    Market Segmentation

    Retinal Surgery Device Market End User Outlook

    • Hospitals
    • Ambulatory Surgical Centers
    • Ophthalmology Clinics

    Retinal Surgery Device Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia-Pacific
    • Middle East and Africa

    Retinal Surgery Device Market Technology Outlook

    • Digital Imaging Technology
    • Robotic-Assisted Technology
    • Laser Technology

    Retinal Surgery Device Market Device Type Outlook

    • Vitrectomy Devices
    • Retinal Lasers
    • Pneumatic Retinopexy Devices
    • Scleral Buckling Devices

    Retinal Surgery Device Market Procedure Type Outlook

    • Vitrectomy
    • Laser Photocoagulation
    • Retinal Detachment Surgery
    • Macular Hole Surgery

    Report Scope

     
    Attribute/Metric Source: Details
    MARKET SIZE 2023 4.5(USD Billion)
    MARKET SIZE 2024 4.7(USD Billion)
    MARKET SIZE 2035 7.5(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 4.34% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2023
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Lumenis, Visionix, Abbott Laboratories, Nidek, Optos, Hoya, Topcon, Carl Zeiss, Heidelberg Engineering, Bausch Health, Novartis, Alcon, Regeneron Pharmaceuticals, Medtronic, CenterVue
    SEGMENTS COVERED Device Type, Procedure Type, End User, Technology, Regional
    KEY MARKET OPPORTUNITIES Growing aging population, Advancements in surgical technology, Increasing prevalence of retinal diseases, Expansion in emerging markets, Rising healthcare expenditure
    KEY MARKET DYNAMICS Technological advancements, Increasing prevalence of retinal disorders, Growing geriatric population, Rising healthcare expenditures, Enhanced awareness and diagnosis
    COUNTRIES COVERED North America, Europe, APAC, South America, MEA

    Leave a Comment

    FAQs

    What is the expected market size of the Global Retinal Surgery Device Market in 2024?

    The Global Retinal Surgery Device Market is expected to be valued at 4.7 billion USD in 2024.

    What will be the estimated market value for the Global Retinal Surgery Device Market by 2035?

    By 2035, the Global Retinal Surgery Device Market is projected to reach approximately 7.5 billion USD.

    What is the expected CAGR for the Global Retinal Surgery Device Market from 2025 to 2035?

    The market is anticipated to grow at a CAGR of 4.34% during the period from 2025 to 2035.

    Which region is projected to hold the largest market share in 2024 for the Global Retinal Surgery Device Market?

    North America is expected to dominate the market with a valuation of 2.0 billion USD in 2024.

    What is the projected market size for Vitrectomy Devices in 2035?

    The market size for Vitrectomy Devices is expected to reach 3.0 billion USD by 2035.

    What will be the market size for Retinal Lasers in 2024?

    Retinal Lasers are projected to have a market size of 1.2 billion USD in 2024.

    Who are the major players in the Global Retinal Surgery Device Market?

    Key players in the market include Lumenis, Abbott Laboratories, Alcon, and Bausch Health.

    What is the estimated market value for Scleral Buckling Devices in 2035?

    Scleral Buckling Devices are expected to be valued at 1.2 billion USD by 2035.

    What is the market size of the APAC region for the Global Retinal Surgery Device Market in 2024?

    The APAC region is expected to have a market size of 0.9 billion USD in 2024.

    What factors are driving the growth of the Global Retinal Surgery Device Market?

    Factors driving market growth include advancing technology and increasing prevalence of retinal disorders.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions